Inhibitors of tyrosine kinases and uses thereof

Details for Australian Patent Application No. 2006336506 (hide)

Owner Pharmacyclics, Inc.

Inventors Palmer, James T.; Honigberg, Lee; Jankowski, Orion D.

Agent Davies Collison Cave

Pub. Number AU-B-2006336506

PCT Pub. Number WO2007/087068

Priority 60/758,617 13.01.06 US

Filing date 28 December 2006

Wipo publication date 2 August 2007

Acceptance publication date 28 June 2012

International Classifications

C07D 471/06 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/416 - condensed with carbocyclic ring systems, e.g. indazole

A61K 31/4375

A61K 31/675 - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

Event Publications

31 July 2008 PCT application entered the National Phase

  PCT publication WO2007/087068 Priority application(s): WO2007/087068

28 June 2012 Application Accepted

  Published as AU-B-2006336506

25 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006336514-Discovery of network nodes and routable addresses

2006336504-1-(benzo [D] [1,3] dioxol-5-yl) -N- (phenyl) cyclopropanecarboxamide derivatives and related compounds as modulators of ATP-Binding Cassette transporters for the treatment of Cystic Fibrosis